Cost-Effectiveness of Inpatient Continuous Glucose Monitoring
Veríssimo et al.
The finding, in our words
In inpatients with type 2 diabetes on intensive insulin therapy, continuous glucose monitoring achieved better glycaemic control than capillary blood glucose testing, with more readings within target range and fewer hyperglycaemic events, and proved cost-effective without increasing hypoglycaemia risk.
A paraphrase to the Library’s standard, never the abstract. The source is one link away and is always the authority.
In adults with type 1 diabetes, Dexcom G7 and FreeStyle Libre 3 showed high accuracy during physical activity, whereas the Simplera system was less accurate; this matters for selecting devices in decentralised monitoring.
Sanfilippo et al., Diabetes, obesity & metabolism · source ↗
Over-the-counter continuous glucose monitors demonstrated reasonable agreement with overall capillary blood glucose trends in individuals without diabetes, yielding an overall mean absolute relative difference of 12.9%. However, sensor accuracy decreased following carbohydrate consumption, suggesting caution is required when using these devices for diagnostic cut-offs or exact-value monitoring.
Prakash et al., Journal of diabetes science and technology (paywalled) · source ↗
In adults with type 2 diabetes and end-stage kidney failure on haemodialysis, real-time continuous glucose monitoring improved time in glycaemic target range and reduced time above range compared with capillary blood glucose testing, while time below range remained minimal and unchanged. This suggests patient-centric glucose monitoring may benefit this high-risk population, though further studies are needed to confirm these benefits.
The study demonstrates that frequent collection of 10 microlitres of capillary blood, combined with wearable sensor data, enables simultaneous measurement of thousands of metabolites, lipids, cytokines and proteins, revealing individualised metabolic and inflammatory responses to dietary interventions and molecular fluctuations linked to intra-day changes in heart rate, glucose, cortisol and physical activity, supporting dynamic health profiling outside the clinic.
Shen et al., Nature biomedical engineering · source ↗
Real-time continuous glucose monitoring proved accurate and reliable in 35 children with diabetic ketoacidosis in a paediatric intensive care unit, with 95% of readings falling within clinically acceptable zones when compared with point-of-care capillary and serum glucose measurements. Acidosis did not impair accuracy, supporting CGM use in acute paediatric care.
Pott et al., Journal of diabetes science and technology (paywalled) · source ↗